The Quest for Biomarkers
(Approx. 17:06 min) Featuring: David Holtzman, MD, Mark Mintun, MD, John Morris, MD, Washington University School of Medicine; Les Shaw, PhD, and John Trojanowski, MD, PhD University of Pennsylvania School of Medicine
Scientists need to know who will develop Alzheimer's and whether the drugs being tested in clinical trials are actually working. This film follows the hunt to find clinical predictors, or biomarkers, that are so critical to solve the problem of Alzheimer's.
Momentum in Science: The Supplementary Series
- Understanding and Attacking Alzheimer's 12 min
- How Far We Have Come in Alzheimer's Research 15 min
- Identifying Mild Cognitive Impairment 20 min
- The Role of Genetics in Alzheimer's 12 min
- Advances in Brain Imaging 11 min
- Looking Into the Future of Alzheimer's 6 min
- The Connection Between Insulin and Alzheimer's 21 min
- Inflammation, the Immune System, and Alzheimer's 29 min
- The Benefit of Diet and Exercise in Alzheimer's 16 min
- Cognitive Reserve: What the Religious Orders Study is Revealing about Alzheimer's 20 min
- Searching for an Alzheimer's Cure: The Story of Flurizan 30 min
- The Pulse of Drug Development 15 min
- The DeMoe Family: Early-Onset Alzheimer's Genetics 25 min
- The Nanney/Felts Family: Late-Onset Alzheimer's Genetics 20 min
- The Quest for Biomarkers 17 min
Connect with Alzheimer's Research
Find out how you can participate in clinical trials or studies, find a research center, or get up-to-date information at 1-800-438-4380.
The Alzheimer's Association 24/7 Helpline provides reliable information and support to all those who need assistance. Call us toll-free anytime day or night at 1-800-272-3900.
Create A Tribute
Honor someone you care about and share your stories by contributing to The Tribute Wall on Facebook.
The Alzheimer's Association message boards and chat rooms are your online communication forum. Share your thoughts and experiences, query your colleagues, and make new friends.
- Scientists are investigating many approaches to treat, prevent, or cure Alzheimer's, with 91 drugs in clinical trials as of 2008 and more in the pipeline awaiting FDA approval to enter human testing.
- Advances in prevention and treatment are only possible thanks to volunteers who participate in clinical trials. At least 50,000 volunteers, both with and without Alzheimer's, are urgently needed to participate in more than 175 actively enrolling Alzheimer's disease trials and studies in the U.S.
- 54% of the adult U.S. population has been touched by Alzheimer's. Read more.